Biotech veteran brings more than two decades of life science experience to Korro’s Board CAMBRIDGE, Mass., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent
November 28, 2023
Venkat Krishnamurthy appointed Senior Vice President, Head of Platform Stephanie Engels appointed Senior Vice President, Head of People and Culture CAMBRIDGE, Mass., November 8, 2022— Korro Bio, Inc ., a leading RNA editing company focused on the discovery and development of novel genetic
November 8, 2022